MarkNtel Advisors recently published a detailed industry analysis of the Biologics Market. The report covers growth trends, geographical marketing strategies, challenges, opportunities, and drivers influencing the market.

Biologics Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2030

The Biologics Market size was valued at USD 412 Billion in 2024 and is projected to reach USD 612 Billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 8.25% during the forecast period, i.e., 2025-2030.

What are the major Driver the Biologics industry?

Increasing Inclination Towards Gene Therapy & Cellular Therapy to Boost the Market Growth – Due to their ability to repair or substitute damaged tissues, gene and cellular treatments have experienced considerable growth in adoption over the historical years. Moreover, the rising investments in research & development of cell and gene therapies have been further bolstering their adoption, owing to the improved efficacy of new drugs. Additionally, there has been increased funding and investments for R&D purposes of cell and gene therapies by companies like Ori Biotech, AstraZeneca Plc, GlaxoSmithKline Biologicals, etc., for the launch of innovative products.

Thus, with enhanced investment, the process of pre-commercialization and market launch has been accelerated, which has been contributing to the market growth. Also, over the historical years, the approvals of these medicines have been accelerated by government organizations like the United States Food and Drug Administration (FDA), the European Medicines Agency (EMA), etc. Consequently, as approvals for cell and gene therapies would accelerate in the coming years, it would create an opportunity for their enhanced adoption in the coming years as well.

Access the detailed PDF Sample report – https://www.marknteladvisors.com/query/request-sample/global-biologics-market.html

What segments define the Biologics market from 2025 to 2030? How do these segments contribute to market dynamics and growth?

·       By Drug Class

• • Recombinant Proteins- Market Size & Forecast 2020-2030, (USD Million)
    • Hormones- Market Size & Forecast 2020-2030, (USD Million)
    • Cytokines- Market Size & Forecast 2020-2030, (USD Million)
  • Monoclonal Antibodies- Market Size & Forecast 2020-2030, (USD Million)
  • Blood & Blood Components- Market Size & Forecast 2020-2030, (USD Million)
  • Cellular & Gene Therapy- Market Size & Forecast 2020-2030, (USD Million)
  • Vaccines- Market Size & Forecast 2020-2030, (USD Million)
  • Others- Market Size & Forecast 2020-2030, (USD Million)

According to report, Monoclonal Antibodies (mAbs) have been gaining traction because of their capability to treat illnesses such as cancers, autoimmune issues, and infections.

·       By Therapeutic Application

• • Oncology- Market Size & Forecast 2020-2030, (USD Million)
  • Infectious Disease- Market Size & Forecast 2020-2030, (USD Million)
  • Autoimmune Disease- Market Size & Forecast 2020-2030, (USD Million)
  • Diabetes- Market Size & Forecast 2020-2030, (USD Million)
  • Cardiovascular Diseases- Market Size & Forecast 2020-2030, (USD Million)
  • Others (Inflammatory Bowel Diseases, Respiratory Disorders, Ophthalmic Disorders, etc.)- Market Size & Forecast 2020-2030, (USD Million)

According to report, The Oncology segment witnessed substantial market growth during historical years.

·        By Source

o   Microbes- Market Size & Forecast 2020-2030, (USD Million)

o   Humans- Market Size & Forecast 2020-2030, (USD Million)

o   Others (Rodents, Plants, etc.)- Market Size & Forecast 2020-2030, (USD Million)

Explore the Complete Biologics Market Analysis Report – https://www.marknteladvisors.com/research-library/global-biologics-market.html

Geographical Analysis: Biologics Market

• Asia-Pacific
• North America
• South America
• Europe
• Middle East & Africa

Biologics Market Share & Competitive Landscape:

The Biologics Market is characterized by intense competition, with several key players driving growth through innovation, market expansion, and strategic investments. The competitive landscape provides valuable insights into the industry's leading companies, highlighting their strengths, financial performance, and market influence.

Leading Companies in the Biologics Market are:

·        Bristol-Myers Squibb

·        Pfizer

·        Sanofi

·        Janssen Biotech, Inc.

·        Bayer AG

·        Merck & Co.

·        Amgen Inc.

·        Abbott GmbH

·        Novartis

·        AstraZeneca Plc

·        GlaxoSmithKline Biologicals

·        Moderna, Inc.

·        Ferring Pharmaceuticals Inc.

·        Aimmune Therapeutics, Inc.

·        F. Hoffman La Roche

Biologics Industry Recent Development:

• 2023: Amgen announced the completion of the acquisition of biologics market player, Horizon Therapeutics, which is aligned with its vision for the development of drugs for patients with rare diseases.
• 2023: AstraZeneca Plc. announced that the Ministry of Health, Labour, and Welfare in Japan approved the extended utilization of Soliris (eculizumab) biologics in the treatment of pediatric patients laid low with generalized myasthenia gravis, particularly those who have no longer responded nicely to different treatment options.

 Questions Addressed in this Study

1.What factors are driving the Biologics Market growth?

2.How is the Biologics Market expected to grow over the next five years?

3.What are the key insights into the current trends in the Biologics Market?

4.What is the current size of the Biologics Market, and how is it projected to change in the future?

6.What is the future outlook for the Biologics Market in terms of technological advancements and market expansion?

For a Customized Analysis Report, Just Drop Your Inquiry Here – https://www.marknteladvisors.com/query/request-customization/global-biologics-market.html

Why MarkNtel Advisors?

MarkNtel Advisors is a leading research, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.

Our specialization in niche industries & emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 15 diverse industrial verticals.

Others Reports:

More Research Studies Report:

-Biocomposites Market size was valued at around USD 36.9 billion in 2024 and is projected to reach USD 89 billion by 2030 with a CAGR of around 16%.

-Green Solvents Market size was valued at around USD 1.34 billion in 2024 & is projected to reach USD 1.87 billion by 2030 with a CAGR of around 5.7%.

For Media Inquiries, Please Contact:

Email: sales@marknteladvisors.com